Why JStar YMAT is trading below its true worth 975 20260511 PZG Paramount delivers outsized Q1 2026 earnings beat but shares fall 335 percent on investor caution The recurring revenue story behind Reliance EZRA Q1 2023 Profit Exceeds Views ATRC AtriCure reports Q4 2025 14 percent revenue growth and wide EPS beat yet shares fall 242 percent Regeneron Pharmaceuticals REGN Dupixent Secures FDA Approval as First Biologic for Pediatric Chronic Spontaneous Urticaria Expanding Blockbuster Drugs Addressable Market Europe Risks AI Dependency Trap as Tech Dominance Shifts to US and Asia Report Warns Google Employee Faces Insider Trading Charges Over 12 Million in Bets Using Internal Data European Stocks Hit Highest Level Since March 2 as USIran Talks Progress Nikkei Breaches 65000 SP 500 Barely Budges as Consumer Stocks Surge Energy Weighs Roth Capital Raises Target TGT Price Target but Flags Q1 as Potential Goldilocks Quarter CMS Energy Analyst Coverage and Market Sentiment Firefly FLY Surges 15 Amid Optimistic Outlook for Space Sector